<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0095">
 <label>19</label>
 <element-citation publication-type="journal" id="rf0085">
  <person-group person-group-type="author">
   <name>
    <surname>Beigel</surname>
    <given-names>J.H.</given-names>
   </name>
   <name>
    <surname>Tebas</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Elie-Turenne</surname>
    <given-names>M.C.</given-names>
   </name>
   <name>
    <surname>Bajwa</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Bell</surname>
    <given-names>T.E.</given-names>
   </name>
   <name>
    <surname>Cairns</surname>
    <given-names>C.B.</given-names>
   </name>
  </person-group>
  <article-title>Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study</article-title>
  <source>Lancet Respir Med</source>
  <volume>5</volume>
  <year>2017</year>
  <fpage>500</fpage>
  <lpage>511</lpage>
  <pub-id pub-id-type="pmid">28522352</pub-id>
 </element-citation>
</ref>
